retatrutide type 2 diabetes trial results 2024 Lilly's triple agonist achieves 16.8% weight loss in phase 3 Lilly's triple agonist, retatrutide, successful

doi: 10.1089/ars.2018.7722

Choosing a selection results in a full page refresh

Metformin hydrochloride Controlled clinical studies of metformin did not include sufficient numbers of elderly patients to determine whether they respond differently from younger patients, although other reported clinical experience has not identified differences in responses between the elderly and young patients

For many people, the transition off the medication or to lower maintenance dosing is also important

While giving women greater control over their bodies, at the same time the pill shifted the responsibility of contraception more firmly onto their shoulders than before

Many surgeons follow patients indefinitely, while others transition care after the first one to two years